Skip to content
Home
News
About Us
Mission & Vision
Message from the CEO
Company Profile
Members
Access
Science & Technology
What Are Diabetes Stem Cells?
Complete Remission of Diabetes.
What Is Biozipcode™?
Cell-Targeting Technology
Academic Collaboration Overview
Dep. of Biocommunication Development (Kyoto Univ)
Domestic & Inter. Research Collaborations
Pipeline Overview
Diabetes Remission Therapy Candidate
Diabetes Stem Cell Biomarker
Biozipcode™ Cell-Targeted Diabetes Therapy
Cell-Targeted Oncology Therapeutics
Cell-Targeted Tissue Regeneration
Research Achievements
Selected Publications
Patents & Intellectual Property
Videos, Lectures & Presentations
For Partners
For Pharmaceutical Com. & Research Instit.
Research Collaboration
Technology Licensing
Co-development
Investment & Strategic Partnerships
Downloads
Contact
Contact Form
Legal & Policies
Privacy Policy
Website Policy
Cookie Policy
Medical & Scientific Disclaimer
Conflict of Interest & Transparency Policy
Japanese
Japanese
Research & Development
Research & Development
カテゴリ
ニュース
未分類
研究・開発
見出し
Advancing diabetes stem cell research toward biomarkers in human peripheral blood.
A Distinct Cell Population Is Elevated in Patients with Type 2 Diabetes
A New Possibility for Assessing Cellular Changes Associated with Diabetes
Publication Details
関連する記事
Page load link
Go to Top